Company profile for GALENA BIOPHARMA

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Our Mission Galena Biopharma, Inc. (NASDAQ: GALE) is a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care. Galena’s development portfolio ranges from mid- to late-stage clinical assets, including a robust immunotherapy program led by NeuVax™ (nelipepimut-S) currently in an international, Phase 3 clini...
Our Mission Galena Biopharma, Inc. (NASDAQ: GALE) is a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care. Galena’s development portfolio ranges from mid- to late-stage clinical assets, including a robust immunotherapy program led by NeuVax™ (nelipepimut-S) currently in an international, Phase 3 clinical trial. The Company’s commercial drugs include Abstral® (fentanyl) Sublingual Tablets and Zuplenz® (ondansetron) Oral Soluble Film. Collectively, Galena’s clinical and commercial strategy focuses on identifying and advancing therapeutic opportunities to improve cancer care, from direct treatment of the disease to the reduction of its debilitating side-effects.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
4640 SW Macadam Ave. Suite 270 Portland, OR 97239
Telephone
Telephone
(503) 400 6610
Client Website
Website
--
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.raps.org/news-and-articles/news-articles/2018/8/senator-grills-fda-over-handling-of-rems-for-trans?feed=Regulatory-Focus

Michael Mezher RAPS
22 Aug 2018

https://endpts.com/in-salvage-effort-sellas-cherry-picks-some-positive-mid-stage-cancer-vaccine-data/

John Carroll ENDPTS
02 Apr 2018

http://www.biospace.com/News/bay-area-galena-biopharma-merges-with-oncology/465669/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews

Alex Keown BIOSPACE
08 Aug 2017

http://www.fiercebiotech.com/biotech/sec-hits-out-at-paid-for-bio-analysts-ceos-and-firms-charges-27

Ben Adams FIERCE BIOTECH
11 Apr 2017

http://www.biospace.com/News/bay-areas-galena-biopharma-exploring-strategic/449232/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews

Mark Terry BIOSPACE
13 Mar 2017

http://www.biospace.com/News/bay-areas-galena-biopharma-ceo-steps-down/445515/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews

 Alex Keown BIOSPACE
01 Feb 2017

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty